156 related articles for article (PubMed ID: 26029733)
1. Tumor cell p38 MAPK: A trigger of cancer bone osteolysis.
Liu H; He J; Yang J
Cancer Cell Microenviron; 2015 Jan; 2(1):. PubMed ID: 26029733
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.
Yang J; He J; Wang J; Cao Y; Ling J; Qian J; Lu Y; Li H; Zheng Y; Lan Y; Hong S; Matthews J; Starbuck MW; Navone NM; Orlowski RZ; Lin P; Kwak LW; Yi Q
Leukemia; 2012 Sep; 26(9):2114-23. PubMed ID: 22425892
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis.
Yang J; Liu Z; Liu H; He J; Yang J; Lin P; Wang Q; Du J; Ma W; Yin Z; Davis E; Orlowski RZ; Hou J; Yi Q
Sci Signal; 2017 Dec; 10(509):. PubMed ID: 29233917
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-like weak inducer of apoptosis regulates particle-induced inflammatory osteolysis via the p38 mitogen-activated protein kinase signaling pathway.
Zhang Z; Fang Y; Wang Q; Sun Y; Xiong C; Cao L; Wang B; Bao N; Zhao J
Mol Med Rep; 2015 Jul; 12(1):1499-505. PubMed ID: 25815691
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
Vanderkerken K; Medicherla S; Coulton L; De Raeve H; Willems A; Lawson M; Van Camp B; Protter AA; Higgins LS; Menu E; Croucher PI
Cancer Res; 2007 May; 67(10):4572-7. PubMed ID: 17495322
[TBL] [Abstract][Full Text] [Related]
6. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
[TBL] [Abstract][Full Text] [Related]
7. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
[TBL] [Abstract][Full Text] [Related]
8. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.
Liu Y; Zhang RX; Yuan W; Chen HQ; Tian DD; Li H; Jiang X; Deng ZL; Wang Y
Cell Physiol Biochem; 2018; 45(5):1759-1771. PubMed ID: 29495003
[TBL] [Abstract][Full Text] [Related]
10. Flavopereirine induces cell cycle arrest and apoptosis via the AKT/p38 MAPK/ERK1/2 signaling pathway in human breast cancer cells.
Yeh HT; Tsai YS; Chen MS; Li YZ; Lin WC; Lee YR; Tseng YS; Sheu SM
Eur J Pharmacol; 2019 Nov; 863():172658. PubMed ID: 31518562
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
Shi YY; Small GW; Orlowski RZ
Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
[TBL] [Abstract][Full Text] [Related]
13. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of mitogen-activated protein kinases in human neutrophils undergoing apoptosis: role in decreased responsiveness to inflammatory cytokines.
Suzuki K; Hasegawa T; Sakamoto C; Zhou YM; Hato F; Hino M; Tatsumi N; Kitagawa S
J Immunol; 2001 Jan; 166(2):1185-92. PubMed ID: 11145700
[TBL] [Abstract][Full Text] [Related]
15. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.
Min Y; Ren X; Vaught DB; Chen J; Donnelly E; Lynch CC; Lin PC
Cancer Res; 2010 Apr; 70(7):2819-28. PubMed ID: 20233869
[TBL] [Abstract][Full Text] [Related]
16. p38 MAPK as a potential therapeutic target for inflammatory osteolysis.
Wei S; Siegal GP
Adv Anat Pathol; 2007 Jan; 14(1):42-5. PubMed ID: 17198310
[TBL] [Abstract][Full Text] [Related]
17. p38 Mitogen-Activated Protein Kinase is Involved in the Pathogenesis of Endometriosis by Modulating Inflammation, but not Cell Survival.
Cakmak H; Seval-Celik Y; Arlier S; Guzeloglu-Kayisli O; Schatz F; Arici A; Kayisli UA
Reprod Sci; 2018 Apr; 25(4):587-597. PubMed ID: 28845752
[TBL] [Abstract][Full Text] [Related]
18. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts.
Abbas S; Clohisy JC; Abu-Amer Y
J Orthop Res; 2003 Nov; 21(6):1041-8. PubMed ID: 14554217
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD26 signaling inhibits human osteoclast development.
Nishida H; Suzuki H; Madokoro H; Hayashi M; Morimoto C; Sakamoto M; Yamada T
J Bone Miner Res; 2014 Nov; 29(11):2439-55. PubMed ID: 24821427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
